Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | COVID-19 Vaccine Covovax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials (Serum Institute of India) |
| BNF code | 1404000ATBPAAAD |
| Virtual Medicinal Product | Generic COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials |
| Name | COVID-19 Vaccine Covovax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials |
| Abbreviated name | COVID-19 Vaccine Covovax 0.5ml inj multidose vials |
| Supplier | Serum Institute of India |
| Current licensing authority | None |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Actual Medicinal Product Packs | |
|---|---|
| COVID-19 Vaccine Covovax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials (Serum Institute of India) 500 dose | |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.